Home / Inspections / 807505

FDA Inspection 807505 — Allina Health Medical Laboratories - Andrology Laboratory

Allina Health Medical Laboratories - Andrology Laboratory — FEI 3005137395

The FDA completed an inspection of Allina Health Medical Laboratories - Andrology Laboratory on November 8, 2012 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 8, 2012
Fiscal Year
2013
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Minneapolis, MN (United States)

Facility

Other inspections at this facility

  • 1087468 (NAI Thu Apr 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 993124 (NAI Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 918655 (NAI Mon Mar 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 725625 (NAI Thu May 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources